2791 - 2800 of 6082 Results
Title
Year
- Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease2021OPENTitle: Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 423Issue #:Start Page: 117365End Page: 117365Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.117365Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009831Citation Count: 18
- Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit2021OPENTitle: Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficitJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 7Start Page: e24837End Page: e24837Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1097/md.0000000000024837Best OA location URL: https://doi.org/10.1097/md.0000000000024837Citation Count: 14
- LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo2021OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 12
- Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohort2021OPENTitle: Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohortJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 6Start Page: 454End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddab058Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/6/454/37875911/ddab058.pdfCitation Count: 28
- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial2021OPENTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 103
-
OPENTitle: A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatisJournal Name: Antimicrobial Agents and ChemotherapyPublisher: American Society for MicrobiologyVol: 65Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/aac.01826-20Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092867Citation Count: 5
- PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data2021OPENTitle: PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic dataJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-020-00993-9Best OA location URL: https://microbiomejournal.biomedcentral.com/track/pdf/10.1186/s40168-020-00993-9Citation Count: 132
-
OPENTitle: Investigating ELOVL7 coding variants in multiple system atrophyJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 749Issue #:Start Page: 135723End Page: 135723Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neulet.2021.135723Best OA location URL: http://manuscript.elsevier.com/S0304394021001014/pdf/S0304394021001014.pdfCitation Count: 2
-
OPENTitle: Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1759Issue #:Start Page: 147372End Page: 147372Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2021.147372Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006086Citation Count: 9
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture2021OPENTitle: Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 3Start Page: 294End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00785-3Best OA location URL: https://nottingham-repository.worktribe.com/preview/5054903/LBD_manuscript_revision.pdfCitation Count: 276